145 related articles for article (PubMed ID: 38913315)
1. Tracking Karyotype Changes in Treatment-Induced Drug-Resistant Evolution.
Ye JC; Heng HH
Methods Mol Biol; 2024; 2825():263-280. PubMed ID: 38913315
[TBL] [Abstract][Full Text] [Related]
2. The Importance of Monitoring Non-clonal Chromosome Aberrations (NCCAs) in Cancer Research.
Heng E; Thanedar S; Heng HH
Methods Mol Biol; 2024; 2825():79-111. PubMed ID: 38913304
[TBL] [Abstract][Full Text] [Related]
3. The New Era of Cancer Cytogenetics and Cytogenomics.
Ye JC; Heng HH
Methods Mol Biol; 2024; 2825():3-37. PubMed ID: 38913301
[TBL] [Abstract][Full Text] [Related]
4. Two-phased evolution: Genome chaos-mediated information creation and maintenance.
Heng J; Heng HH
Prog Biophys Mol Biol; 2021 Oct; 165():29-42. PubMed ID: 33992670
[TBL] [Abstract][Full Text] [Related]
5. Genome chaos: Creating new genomic information essential for cancer macroevolution.
Heng J; Heng HH
Semin Cancer Biol; 2022 Jun; 81():160-175. PubMed ID: 33189848
[TBL] [Abstract][Full Text] [Related]
6. Challenges and Opportunities for Clinical Cytogenetics in the 21st Century.
Heng E; Thanedar S; Heng HH
Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833419
[TBL] [Abstract][Full Text] [Related]
7. Clonal and non-clonal chromosome aberrations and genome variation and aberration.
Heng HH; Liu G; Bremer S; Ye KJ; Stevens J; Ye CJ
Genome; 2006 Mar; 49(3):195-204. PubMed ID: 16604101
[TBL] [Abstract][Full Text] [Related]
8. Stochastic cancer progression driven by non-clonal chromosome aberrations.
Heng HH; Stevens JB; Liu G; Bremer SW; Ye KJ; Reddy PV; Wu GS; Wang YA; Tainsky MA; Ye CJ
J Cell Physiol; 2006 Aug; 208(2):461-72. PubMed ID: 16688757
[TBL] [Abstract][Full Text] [Related]
9. Why it is crucial to analyze non clonal chromosome aberrations or NCCAs?
Heng HH; Regan SM; Liu G; Ye CJ
Mol Cytogenet; 2016; 9():15. PubMed ID: 26877768
[TBL] [Abstract][Full Text] [Related]
10. Cancer progression by non-clonal chromosome aberrations.
Heng HH; Bremer SW; Stevens J; Ye KJ; Miller F; Liu G; Ye CJ
J Cell Biochem; 2006 Aug; 98(6):1424-35. PubMed ID: 16676347
[TBL] [Abstract][Full Text] [Related]
11. What Is Karyotype Coding and Why Is Genomic Topology Important for Cancer and Evolution?
Ye CJ; Stilgenbauer L; Moy A; Liu G; Heng HH
Front Genet; 2019; 10():1082. PubMed ID: 31737054
[TBL] [Abstract][Full Text] [Related]
12. Relapse and cytogenetic evolution in myeloid neoplasms.
Ertz-Archambault N; Kelemen K
Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
[TBL] [Abstract][Full Text] [Related]
13. Genome based cell population heterogeneity promotes tumorigenicity: the evolutionary mechanism of cancer.
Ye CJ; Stevens JB; Liu G; Bremer SW; Jaiswal AS; Ye KJ; Lin MF; Lawrenson L; Lancaster WD; Kurkinen M; Liao JD; Gairola CG; Shekhar MP; Narayan S; Miller FR; Heng HH
J Cell Physiol; 2009 May; 219(2):288-300. PubMed ID: 19115235
[TBL] [Abstract][Full Text] [Related]
14. Genome chaos: survival strategy during crisis.
Liu G; Stevens JB; Horne SD; Abdallah BY; Ye KJ; Bremer SW; Ye CJ; Chen DJ; Heng HH
Cell Cycle; 2014; 13(4):528-37. PubMed ID: 24299711
[TBL] [Abstract][Full Text] [Related]
15. Experimental Induction of Genome Chaos.
Ye CJ; Liu G; Heng HH
Methods Mol Biol; 2018; 1769():337-352. PubMed ID: 29564834
[TBL] [Abstract][Full Text] [Related]
16. Cancer drug resistance: the central role of the karyotype.
Duesberg P; Li R; Sachs R; Fabarius A; Upender MB; Hehlmann R
Drug Resist Updat; 2007; 10(1-2):51-8. PubMed ID: 17387035
[TBL] [Abstract][Full Text] [Related]
17. Step-wise and punctuated genome evolution drive phenotype changes of tumor cells.
Stepanenko A; Andreieva S; Korets K; Mykytenko D; Huleyuk N; Vassetzky Y; Kavsan V
Mutat Res; 2015 Jan; 771():56-69. PubMed ID: 25771981
[TBL] [Abstract][Full Text] [Related]
18. Micronuclei and Genome Chaos: Changing the System Inheritance.
Ye CJ; Sharpe Z; Alemara S; Mackenzie S; Liu G; Abdallah B; Horne S; Regan S; Heng HH
Genes (Basel); 2019 May; 10(5):. PubMed ID: 31086101
[TBL] [Abstract][Full Text] [Related]
19. Karyotype heterogeneity and unclassified chromosomal abnormalities.
Heng HH; Liu G; Stevens JB; Abdallah BY; Horne SD; Ye KJ; Bremer SW; Chowdhury SK; Ye CJ
Cytogenet Genome Res; 2013; 139(3):144-57. PubMed ID: 23571381
[TBL] [Abstract][Full Text] [Related]
20. Genome Chaos, Information Creation, and Cancer Emergence: Searching for New Frameworks on the 50th Anniversary of the "War on Cancer".
Heng J; Heng HH
Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
